Print

Print


There are now 15 co-sponsors - the newest is
Sen Levin, Carl - 5/15/2001

Please contact your senators and ask them to co-sponsor S.723
Linda Herman

S.723
Sponsor: Sen Specter, Arlen (introduced 4/5/2001)
Latest Major Action: 4/5/2001 Referred to Senate committee
Title: A bill to amend the Public Health Service Act to provide for human
embryonic stem cell generation and research.
COSPONSORS(15), BY DATE
Sen Harkin, Tom - 4/5/2001
Sen Thurmond, Strom - 4/5/2001
Sen Chafee, Lincoln D. - 4/5/2001
Sen Smith, Gordon - 4/5/2001
Sen Hollings, Ernest F. - 4/5/2001
Sen Reid, Harry M. - 4/5/2001
Sen Murray, Patty - 4/5/2001
Sen Clinton, Hillary Rodham - 4/5/2001
Sen Corzine, Jon - 4/5/2001
Sen Feinstein, Dianne - 4/5/2001
Sen Kerry, John F. - 4/5/2001
Sen Inouye, Daniel K. - 4/5/2001
Sen Jeffords, James M. - 5/1/2001
Sen Lieberman, Joseph I. - 5/1/2001
Sen Levin, Carl - 5/15/2001


Stem Cell Research Act of 2001 (Introduced in the Senate)
S 723 IS
107th CONGRESS
1st Session
S. 723

To amend the Public Health Service Act to provide for human embryonic
stem cell generation and research.
IN THE SENATE OF THE UNITED STATES
April 5, 2001

Mr. SPECTER (for himself, Mr. HARKIN, Mr. THURMOND, Mr. CHAFEE, Mr. SMITH
of Oregon, Mr. HOLLINGS, Mr. REID, Mrs. MURRAY, Mrs. CLINTON, Mr.
CORZINE, Mrs. FEINSTEIN, Mr. KERRY, and Mr. INOUYE) introduced the
following bill; which was read twice and referred to the Committee on
Health, Education, Labor, and Pensions


A BILL
To amend the Public Health Service Act to provide for human embryonic
stem cell generation and research.
Be it enacted by the Senate and House of Representatives of the United
States of
America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the 'Stem Cell Research Act of 2001'.
SEC. 2. HUMAN EMBRYONIC STEM CELL GENERATION AND RESEARCH.
Part H of the Title IV of the Public Health Service Act (42 U.S.C. 289 et
seq.) is amended by inserting after section 498B the following:
'SEC. 498C. HUMAN EMBRYONIC STEM CELL GENERATION AND RESEARCH.
'(a) IN GENERAL- Notwithstanding any other provision of law, the
Secretary may only conduct, support, or fund research on human embryos
for the purpose of generating embryonic stem cells and utilizing stem
cells that have been derived from embryos in accordance with this
section.
'(b) SOURCES OF EMBRYONIC STEM CELLS- For purposes of carrying out
research under subsection (a), the human embryonic stem cells involved
shall be derived only from embryos that have been donated from in-vitro
fertilization clinics after compliance with the following:
'(1) Prior to the consideration of embryo donation and through
consultation with the
progenitors, it is determined that the embryos will never be implanted in
a woman and would otherwise be discarded.
'(2) The embryos are donated with the written informed consent of the
progenitors.
'© RESTRICTIONS-
'(1) IN GENERAL- The following restriction shall apply with respect to
human
embryonic stem cell research conducted or supported under subsection (a):
'(A) The research involved shall not result in the creation of human
embryos.
'(B) The research involved shall not result in the reproductive cloning
of a human
being.
'(2) PROHIBITION-
'(A) IN GENERAL- It shall be unlawful for any person receiving Federal
funds
to knowingly acquire, receive, or otherwise transfer any human embryos
for
valuable consideration if the acquisition, receipt, or transfer affects
interstate
commerce.
'(B) DEFINITION- In subparagraph (A), the term 'valuable consideration'
does
not include reasonable payments associated with transportation,
transplantation,
processing, preservation, quality control, or storage.
'(d) GUIDELINES- The Secretary, in conjunction with the Director of the
National Institutes of Health, shall issue guidelines that expand on the
rules governing human embryonic stem cell research (as in effect on the
date of enactment of this section) to include rules that govern the
derivation of stem cells from donated embryos under this section.
'(e) REPORTING REQUIREMENTS.- The Secretary shall annually prepare and
submit to the appropriate committees of Congress a report describing the
activities carried out under this section during the preceding fiscal
year, and including a description of whether and to what extent research
under subsection (a) has been conducted in accordance with this
section.'.


Source; THOMAS
thomas.loc.gov

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn